The DOI matches its Crossref record; 271 of the 271 references it cites were found in a registry or an index.
Computational methods in drug discovery
Open accessAbstract
The process for drug discovery and development is challenging, time consuming and expensive. Computer-aided drug discovery (CADD) tools can act as a virtual shortcut, assisting in the expedition of this long process and potentially reducing the cost of research and development. Today CADD has become an effective and indispensable tool in therapeutic development. The human genome project has made available a substantial amount of sequence data that can be used in various drug discovery projects. Additionally, increasing knowledge of biological structures, as well as increasing computer power have made it possible to use computational methods effectively in various phases of the drug discovery and development pipeline. The importance of in silico tools is greater than ever before and has advanced pharmaceutical research. Here we present an overview of computational methods used in different facets of drug discovery and highlight some of the recent successes. In this review, both structure-based and ligand-based drug discovery methods are discussed. Advances in virtual high-throughput screening, protein structure prediction methods, protein–ligand docking, pharmacophore modeling and QSAR techniques are reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–271 of 271
Can we use docking and scoring for hit-to-lead optimization?
Enyedy, I. J., & Egan, W. J. (2008) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-007-9165-4 · Cited by 100
pKa based protonation states and microspecies for protein–ligand docking
ten Brink, T., & Exner, T. E. (2010) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-010-9385-x · Cited by 99
Terp, G. E., Johansen, B. N., Christensen, I. T., & Jørgensen, F. S. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm001090l · Cited by 97
PEP-SiteFinder: a tool for the blind identification of peptide binding sites on protein surfaces
Saladin, A., Rey, J., Thévenet, P., Zacharias, M., Moroy, G., & Tufféry, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku404 · Cited by 97
CABS-fold: server for the de novo and consensus-based prediction of protein structure
Błaszczyk, M., Jamróz, M. H., Kmiecik, S., & Koliński, A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt462 · Cited by 94
EM-Fold: De Novo Atomic-Detail Protein Structure Determination from Medium-Resolution Density Maps
Lindert, S., Alexander, N. S., Woetzel, N., Karakaş, M., Stewart, P. L., & Meiler, J. (2012) · Structure · doi:10.1016/j.str.2012.01.023 · Cited by 92
Self-citationCapsaicin Interaction with TRPV1 Channels in a Lipid Bilayer: Molecular Dynamics Simulation
Hanson, S. M., Newstead, S. L., Swartz, K. J., & Sansom, M. S. P. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2015.02.013 · Cited by 92
Puri, M., Solanki, A., Padawer, T., Tipparaju, S. M., Moreno, W. A., & Pathak, Y. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801559-9.00001-6 · Cited by 90
Lindert, S., Staritzbichler, R., Woetzel, N., Karakaş, M., Stewart, P. L., & Meiler, J. (2009) · Structure · doi:10.1016/j.str.2009.06.001 · Cited by 89
Self-citationChemical feature-based pharmacophores and virtual library screening for discovery of new leads.
Langer, T., & Krovat, E. M. (2003) · PubMed · Cited by 86
A Model for the Solution Structure of the Rod Arrestin Tetramer
Hanson, S. M., Dawson, E. S., Francis, D. J., Eps, N. V., Klug, C. S., Hubbell, W. L., Meiler, J., & Gurevich, V. V. (2008) · Structure · doi:10.1016/j.str.2008.03.006 · Cited by 83
Flexible receptor docking for drug discovery
Wong, C. F. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1078308 · Cited by 81
Free Energy Calculations to Estimate Ligand-Binding Affinities in Structure-Based Drug Design
Reddy, M. R., Reddy, C. R., Rathore, R. S., et al. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990604 · Cited by 76
Modeling Protein−Ligand Binding by Mining Minima
Chen, W., Gilson, M. K., Webb, S. J., & Potter, M. J. (2010) · Journal of Chemical Theory and Computation · doi:10.1021/ct100245n · Cited by 74
Application of in silico approaches to predicting drug–drug interactions
Ekins, S., & Wrighton, S. A. (2001) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(01)00119-8 · Cited by 73
Rigorous Free Energy Calculations in Structure‐Based Drug Design
Michel, J., Foloppe, N., & Essex, J. (2010) · Molecular Informatics · doi:10.1002/minf.201000051 · Cited by 73
Bergström, C. A. S. (2005) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2005.pto960303.x · Cited by 71
Strategies for Indirect Computer-Aided Drug Design
Loew, G. H., Villar, H. O., & Alkorta, I. (1993) · Pharmaceutical Research · doi:10.1023/a:1018977414572 · Cited by 70
Hit Identification and Binding Mode Predictions by Rigorous Free Energy Simulations
Michel, J., & Essex, J. W. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800524s · Cited by 70
Computational Prediction of Drug Solubility in Fasted Simulated and Aspirated Human Intestinal Fluid
Fagerberg, J. H., Karlsson, Ε., Ulander, J., Hanisch, G., & Bergström, C. A. S. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1487-z · Cited by 70
Multi-Conformer Ensemble Docking to Difficult Protein Targets
Ellingson, S. R., Miao, Y., Baudry, J. Y., & Smith, J. C. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp506511p · Cited by 69
Ensemble-Based Docking Using Biased Molecular Dynamics
Campbell, A. J., Lamb, M. L., & Joseph‐McCarthy, D. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400729j · Cited by 68
Darnag, R., Mazouz, E. L. M., Schmitzer, A. R., Villemin, D., Jarid, A., & Cherqaoui, D. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.01.002 · Cited by 66
From Docking False-Positive to Active Anti-HIV Agent
Barreiro, G., Kim, J. T., Guimarães, C. R. W., Bailey, C. M., Domaoal, R. A., Wang, L., Anderson, K. S., & Jorgensen, W. L. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070683u · Cited by 65
Comparative Modeling: The State of the Art and Protein Drug Target Structure Prediction
Liu, T., Tang, G. W., & Capriotti, E. (2011) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620711795767811 · Cited by 65
Faller, C. E., Raman, E. P., MacKerell, A. D., & Guvench, O. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2486-8_7 · Cited by 64
Mendenhall, J., & Meiler, J. (2016) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-016-9895-2 · Cited by 63
Pharmacophore Perception, Development and Use in Drug Design. Edited by Osman F. Güner
Lin, S. (2000) · Molecules · doi:10.3390/50700987 · Cited by 61
Fukunishi, Y., & Nakamura, H. (2010) · Protein Science · doi:10.1002/pro.540 · Cited by 60
Durrant, J. D., Lindert, S., & McCammon, J. A. (2013) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2013.05.006 · Cited by 60
Self-citationPrediction of Caco-2 cell permeability using a combination of MO-calculation and neural network
Fujiwara, S., Yamashita, F., & Hashida, M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00045-5 · Cited by 60
Virtual screening of the inhibitors targeting at the viral protein 40 of Ebola virus
Karthick, V., Nagasundaram, N., Doss, C. G. P., Chakraborty, C., Ramamoorthy, S., Lü, A., Zhang, G., & Zhu, H. (2016) · Infectious Diseases of Poverty · doi:10.1186/s40249-016-0105-1 · Cited by 60
Hänsch, C., McClarin, J. A., Klein, T. E., & Langridge, R. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12553-4 · Cited by 56
Singh, N., Chevé, G., Ferguson, D. M., & McCurdy, C. R. (2006) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-006-9067-x · Cited by 55
Scarsi, M., Podvinec, M., Roth, A. B., Hug, H., Kersten, S., Albrecht, H., Schwede, T. F., Meyer, U., & Rücker, C. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.024596 · Cited by 52
Ghersi, D., & Sánchez, R. (2011) · Journal of Structural and Functional Genomics · doi:10.1007/s10969-011-9110-6 · Cited by 51
Biological Function and Molecular Mapping of M Antigen in Yeast Phase of Histoplasma capsulatum
Guimaraes, A. J., Hamilton, A. J., Guedes, H. L. D. M., Nosanchuk, J. D., & Zancopé‐Oliveira, R. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003449 · Cited by 50
Protein Structure Prediction in Structure Based Drug Design
Takeda‐Shitaka, M., Takaya, D., Chiba, C., et al. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455837 · Cited by 50
Predicting protein–ligand binding affinities: a low scoring game?
Marsden, P. M., Puvanendrampillai, D., Mitchell, J. B. O., & Glen, R. C. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b409570g · Cited by 48
Mueller, R., Rodriguez, A. L., Dawson, E. S., Butkiewicz, M., Nguyen, T., Oleszkiewicz, S., Bleckmann, A., Weaver, C. D., Lindsley, C. W., Conn, P. J., et al. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn9000389 · Cited by 47
Farnesyl Diphosphate Synthase Inhibitors fromIn SilicoScreening
Lindert, S., Zhu, W., Liu, Y., et al. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12121 · Cited by 46
Self-citationExploring Transmembrane Diffusion Pathways With Molecular Dynamics
Wang, Y., Shaikh, S. A., & Tajkhorshid, E. (2010) · Physiology · doi:10.1152/physiol.00046.2009 · Cited by 45
Fischer, B., Fukuzawa, K., & Wenzel, W. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21607 · Cited by 44
Huang, S., Li, M., Wang, J., & Pan, Y. F. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00275 · Cited by 42
Liu, Y.-L., Lindert, S., Zhu, W., Wang, K., McCammon, J. A., & Oldfield, E. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409061111 · Cited by 41
Self-citationSupport vector machine applied in QSAR modelling
Hu, M. Y., Zhou, Y., Liang, G., & Li, Z. (2005) · Chinese Science Bulletin · doi:10.1007/bf03183737 · Cited by 41
Sova, M., Čadež, G., Turk, S., Majce, V., Polanc, S., Batson, S., Lloyd, A. J., Roper, D. I., Fishwick, C. W. G., & Gobec, S. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.034 · Cited by 40
Accurate protein structure modeling using sparse NMR data and homologous structure information
Thompson, J. M., Sgourakis, N. G., Liu, G., Rossi, P., Tang, Y., Mills, J., Szyperski, T., Montelione, G. T., & Baker, D. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202485109 · Cited by 39
Lindert, S., Bucher, D., Eastman, P. K., Pande, V. S., & McCammon, J. A. (2013) · Journal of Chemical Theory and Computation · doi:10.1021/ct400514p · Cited by 39
Self-citationAccelerated Molecular Dynamics in Computational Drug Design
Wereszczynski, J., & McCammon, J. A. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-465-0_30 · Cited by 35
Consensus Scoring with Feature Selection for Structure-Based Virtual Screening
Teramoto, R., & Fukunishi, H. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci700239t · Cited by 35
Hu, L., Chen, G., & Chau, R. M. W. (2005) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2005.09.002 · Cited by 35
Wells, M. M., Tillman, T. S., Mowrey, D. D., Sun, T., Xu, Y., & Tang, P. S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501873p · Cited by 34
Triballeau, N., Name, E. V., Laslier, G., Cai, D., Paillard, G., Sorensen, P. W., Hoffmann, R. D., Bertrand, H., Ngai, J., & Acher, F. (2008) · Neuron · doi:10.1016/j.neuron.2008.11.014 · Cited by 32
A Molecular Dynamics Ensemble-Based Approach for the Mapping of Druggable Binding Sites
Ivetac, A., & McCammon, J. A. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-465-0_1 · Cited by 29
Site-Specific Fragment Identification Guided by Single-Step Free Energy Perturbation Calculations
Raman, E. P., Vanommeslaeghe, K., & MacKerell, A. D. (2012) · Journal of Chemical Theory and Computation · doi:10.1021/ct300088r · Cited by 29
Damm‐Ganamet, K. L., Bembenek, S. D., Venable, J. W., Castro, G., Mangelschots, L., Peeters, D. C. G., McAllister, H., Edwards, J. P., DiSepio, D., & Mirzadegan, T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01974 · Cited by 27
Distance Dependent Scoring Function for Describing Protein−Ligand Intermolecular Interactions
Artemenko, N. V. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci700224e · Cited by 25
LigMerge: A Fast Algorithm to Generate Models of Novel Potential Ligands from Sets of Known Binders
Lindert, S., Durrant, J. D., & McCammon, J. A. (2012) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2012.01414.x · Cited by 25
Self-citationMartin, O., & Schomburg, D. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21603 · Cited by 24
Synthesis of de novo designed small-molecule inhibitors of bacterial RNA polymerase
Agarwal, A. K., Johnson, A. P., & Fishwick, C. W. G. (2008) · Tetrahedron · doi:10.1016/j.tet.2008.08.037 · Cited by 23
Automated site preparation in physics‐based rescoring of receptor ligand complexes
Rapp, C. S., Schonbrun, C., Jacobson, M. P., Kalyanaraman, C., & Huang, N. (2009) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22415 · Cited by 22
Protein Fold Recognition and Threading
McGuffin, L. J. (2008) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789812778789_0002 · Cited by 21
Virtual High-Throughput Screening To Identify Novel Activin Antagonists
Zhu, J., Mishra, R. K., Schiltz, G. E., Makanji, Y., Scheidt, K. A., Mazar, A. P., & Woodruff, T. K. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00753 · Cited by 21
Protein structure prediction methods for drug design
Lengauer, T., & Zimmer, R. (2000) · Briefings in Bioinformatics · doi:10.1093/bib/1.3.275 · Cited by 19
Integration of Ligand and Structure Based Approaches for CSAR-2014
Prathipati, P., & Mizuguchi, K. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00477 · Cited by 14
Homology Modeling of Cannabinoid Receptors: Discovery of Cannabinoid Analogues for Therapeutic Use
Chang, C. A., Ai, R., Gutierrez, M., & Marsella, M. J. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-465-0_35 · Cited by 12
Fold recognition for drug discovery
Mizuguchi, K. (2004) · Drug Discovery Today TARGETS · doi:10.1016/s1741-8372(04)02392-8 · Cited by 11
Hu, Y., & Liu, H. (2014) · The Journal of Physical Chemistry A · doi:10.1021/jp503856h · Cited by 5
PQSAR: The membrane quantitative structure-activity relationships in cheminformatics
Adl, A., Zein, M., & Hassanien, A. E. (2016) · Expert Systems with Applications · doi:10.1016/j.eswa.2016.01.051 · Cited by 4
(1998) · doi:10.1002/(sici)1096-987x(19981115)19:14<1639::aid-jcc10>3.0.co;2-b
Cited by
Kinase inhibitors: the road ahead
Ferguson, F. M., & Gray, N. S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.21 · Cited by 1,009
Machine Learning in Drug Discovery: A Review
Dara, S., Dhamercherla, S., Jadav, S. S., Babu, C. M., & Ahsan, M. J. (2022) · Artificial Intelligence Review · doi:10.1007/s10462-021-10058-4 · Cited by 792
Sabe, V. T., Ntombela, T., Jhamba, L. A., Maguire, G. E. M., Govender, T., Naicker, T., & Kruger, H. G. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113705 · Cited by 625
Structure-Based Virtual Screening: From Classical to Artificial Intelligence
Maia, E. H. B., Assis, L. C., de Oliveira, T. A., da Silva, A. M., & Taranto, A. G. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00343 · Cited by 588
Machine Learning Methods in Drug Discovery
Patel, L., Shukla, T., Huang, X., Ussery, D. W., & Wang, S. (2020) · Molecules · doi:10.3390/molecules25225277 · Cited by 460
Metadata
- Authors
- Leelananda, S. P., & Lindert, S.
- Venue
- Beilstein Journal of Organic Chemistry
- Publisher
- Beilstein Institut
- Published
- 2016-12-12
- Volume
- 12
- Pages
- 2694-2718
- ISSN
- 1860-5397 (ISSN-L)
- OpenAlex
- W2567231876
- Cited by
- 639
- References
- 271
- FWCI
- 33.64
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.